6810.TWO Bio Preventive Medicine Corp.

Healthcare Biotechnology Taiwan OTC Exchange
20.20 TWD
Close of Nov 6, 2026
16.50 46.00
Market cap
TWD 999M
P/E
-
P/B
4.07x
ROE
-32.5%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the fiscal year ending Dec 2025.

Is 6810.TWO undervalued?

Graham number

The Graham number of Bio Preventive Medicine Corp. cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Bio Preventive Medicine Corp. fundamental analysis

No fundamental analysis for Bio Preventive Medicine Corp. yet.

Bio Preventive Medicine Corp. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Bio Preventive Medicine Corp.

Bio Preventive Medicine Corp., a clinical-staged biotech company, focusing on early detection and prevention of diseases. The company offers solutions in prevention, screening, and monitoring chronic diseases and cancers management. It also provides DNlite test, a series of patented and clinically validated non-invasive urine test for monitoring the progression of diabetic nephropathy, including DNlite-IVD103 and DNlite-DN_Score. Bio Preventive Medicine Corp. was founded in …

Full company profile